Earth Science Tech, Inc. (ETST) stock
ETSTOTCPharmaceutical PreparationsFiscal year ends March 31
$0.09+0.00 (+3.73%)
Close on Oct 19, 2026Market cap $25.57MP/E 9.8Yield –
Earth Science Tech total assets
Total assets on the balance sheet at the end of each period.
Earth Science Tech's total assets was $10.37M at Jun 30, 2026. For fiscal 2026 it was $8.97M, up 26.9% from the year before. Over ten years it grew 25.8% a year on average. The highest annual figure on record is $8.97M in fiscal 2026.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $8.97M | +26.9% |
| FY2025 | Mar 31, 2025 | $7.07M | +82.1% |
| FY2024 | Mar 31, 2024 | $3.88M | +42.3% |
| FY2023 | Mar 31, 2023 | $2.73M | +3445.5% |
| FY2022 | Mar 31, 2022 | $76.94K | +19.2% |
| FY2021 | Mar 31, 2021 | $64.56K | -58.2% |
| FY2020 | Mar 31, 2020 | $154.55K | -62.4% |
| FY2019 | Mar 31, 2019 | $411.07K | +19.0% |
| FY2018 | Mar 31, 2018 | $345.33K | -55.4% |
| FY2015 | Mar 31, 2015 | $773.73K | -14.5% |
| FY2014 | Mar 31, 2014 | $904.95K | +18927.6% |
| FY2013 | Mar 31, 2013 | $4.76K | -63.8% |
| FY2012 | Mar 31, 2012 | $13.15K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $10.37M | +33.4% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $8.97M | +26.9% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $8.09M | +41.7% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $8.67M | +71.6% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $7.78M | +63.0% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $7.07M | +82.1% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $5.71M | +73.8% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $5.05M | +64.0% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $4.77M | +62.0% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $3.88M | +42.3% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $3.28M | +511.1% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $3.08M | +765.6% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $2.95M | +819.4% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $2.73M | +3445.5% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $537.38K | +1992.6% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $355.76K | +564.7% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $320.32K | +721.4% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $76.94K | +19.2% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $25.68K | -75.1% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $53.53K | -60.9% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $39.00K | -70.6% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $64.56K | -58.2% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $103.24K | -45.6% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $137.04K | -55.1% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $132.81K | -62.3% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $154.55K | -62.4% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $189.71K | -63.9% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $305.25K | -56.6% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $352.37K | -19.1% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $411.07K | +19.0% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $525.17K | +28.1% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $704.15K | +80.2% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $435.60K | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $345.33K | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | $410.13K | – |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | $390.84K | – |
See a number that looks wrong?